The microtubule associated protein tau (MAPT) is a key mediator of neurodegeneration in Alzheimer’s disease and related disorders. This symposium will address the potential of tau-related targets for immunotherapy, across the spectrum of tauopathies. We will review the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic strategy for Alzheimer’s disease and other devastating neurodegenerative disorders.
Reception to follow.
Call for Abstracts
Abstract submissions are invited for a poster session. For complete submission instructions, please send an email to Tau2017@nyas.org with the words "Abstract Information" in the subject line. Two abstracts will be selected for short talks at the symposium. The deadline for abstract submission is January 13, 2017.
|Member (Student / Postdoc / Resident / Fellow)
|Nonmember (Student / Postdoc / Resident / Fellow)
The Brain Dysfunction Discussion Group is proudly supported by